Simcere Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:S2P Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
10 Jul 26	Sell€72,703	Jinsheng Ren	Individual	53,000	€1.37
09 Jul 26	Sell€131,722	Jinsheng Ren	Individual	100,000	€1.32
06 Jul 26	Sell€135,422	Jinsheng Ren	Individual	100,000	€1.35
15 Jun 26	Buy€111,664	Jinsheng Ren	Individual	100,000	€1.12
26 May 26	Buy€112,688	Jinsheng Ren	Individual	100,000	€1.13
08 Apr 26	Sell€61,991,280	Simcere Pharmaceutical Group	Company	44,952,853	€1.38
10 Sep 25	Buy€171,625,754	Simcere Pharmaceutical Group	Company	121,000,000	€1.42

Insider Trading Volume

Insider Buying: S2P insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of S2P?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	127,135,431	4.95%
Institutions	271,494,972	10.6%
General Public	562,238,096	21.9%
Private Companies	1,607,330,119	62.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 76.52% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
34.8%	Simcere Pharmaceutical Group	893,478,836	€1.2b	-4.79%	no data
23.1%	New Good Management Limited	592,810,031	€797.5m	0%	no data
4.83%	Jinsheng Ren	124,139,978	€167.0m	0.19%	no data
4.71%	Fortune Fountain Investment Limited	120,961,370	€162.7m	0%	no data
1.4%	Vanguard Capital Management, LLC	36,063,000	€48.5m	6.62%	no data
0.87%	Principal Global Investors, LLC	22,342,000	€30.1m	0%	0.01%
0.71%	BlackRock, Inc.	18,296,000	€24.6m	-7.73%	no data
0.67%	China Universal Asset Management Company Ltd.	17,278,000	€23.2m	0%	0.07%
0.62%	Fullgoal Fund Management Co. Ltd.	15,925,000	€21.4m	0%	0.04%
0.5%	Yinhua Fund Management Co., Ltd.	12,868,000	€17.3m	0%	0.09%
0.41%	ICBC Credit Suisse Fund Management Co., Ltd	10,640,163	€14.3m	0%	0.05%
0.4%	Essence Fund Management Co., Ltd	10,152,000	€13.7m	0%	0.35%
0.37%	Dimensional Fund Advisors LP	9,376,361	€12.6m	10.3%	no data
0.36%	Fullgoal Asset Management (HK) Limited	9,261,000	€12.5m	0%	2.97%
0.35%	China Asset Management Co. Ltd.	8,960,190	€12.1m	2.74%	0.01%
0.34%	E Fund Management Co., Ltd.	8,676,360	€11.7m	1.26%	0.01%
0.3%	American Century Investment Management Inc	7,681,000	€10.3m	26.9%	no data
0.3%	Norges Bank Investment Management	7,659,620	€10.3m	0%	no data
0.27%	ICBC UBS Asset Management (International) Company Limited	6,838,000	€9.2m	0%	1.14%
0.25%	Goldman Sachs Asset Management, L.P.	6,438,000	€8.7m	-20.3%	no data
0.24%	Morgan Stanley	6,228,541	€8.4m	0%	no data
0.23%	Caitong Fund Management Co., Ltd.	5,847,478	€7.9m	0%	0.22%
0.2%	Bosera Asset Management Co., Ltd.	5,137,000	€6.9m	0%	0.03%
0.16%	HuaAn Fund Management Company Ltd.	4,173,000	€5.6m	0%	0.02%
0.15%	Zhong Ou Fund Management Co., Ltd	3,952,000	€5.3m	0%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/08/13 00:18
End of Day Share Price	2026/08/13 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Simcere Pharmaceutical Group Limited is covered by 18 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Shaojing Tong	BofA Global Research
Bo Yu	China International Capital Corporation Limited
Zhu Chen	Citic Securities Co., Ltd.